{"title":"VASODILATORS FOR THE TREATMENT OF CARDIAC DISEASES (С01D) ON THE PHARMACEUTICAL MARKET OF THE REPUBLIC OF BELARUS","authors":"S. E. Rzheussky, P. S. Varabei","doi":"10.52540/2074-9457.2021.2.33","DOIUrl":null,"url":null,"abstract":"The article studies the domestic market of vasodilators for cardiac diseases in Belarus by analyzing and comparing secondary marketing information. The structure of the market depending on the manufacturing country was studied. It was established that medicines containing isosorbide mononitrate/dinitrate have the greatest number of indications to use and the least number of side effects. The dynamics of changing the sales of medicines in the vasodilators group for cardiac diseases for the period 2010-2018 is presented. The market attractiveness of medicines of the vasodilators group for cardiac diseases was studied using the matrix of the Boston Consulting Group (BCG matrix).","PeriodicalId":23657,"journal":{"name":"Vestnik Farmacii","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik Farmacii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52540/2074-9457.2021.2.33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The article studies the domestic market of vasodilators for cardiac diseases in Belarus by analyzing and comparing secondary marketing information. The structure of the market depending on the manufacturing country was studied. It was established that medicines containing isosorbide mononitrate/dinitrate have the greatest number of indications to use and the least number of side effects. The dynamics of changing the sales of medicines in the vasodilators group for cardiac diseases for the period 2010-2018 is presented. The market attractiveness of medicines of the vasodilators group for cardiac diseases was studied using the matrix of the Boston Consulting Group (BCG matrix).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
